ArticleCureus2025
Primary Non-Hodgkin Lymphoma of the Urinary Bladder in the Paediatric Age Group: A Report of a Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary non-Hodgkin lymphoma (NHL) of the urinary bladder in the paediatric age group is an unusual neoplasm. Patients mostly present with haematuria, lower urinary tract symptoms and abdominal pain. The clinical, radiological and histological findings are non-specific. It is difficult to differentiate it from more common congeners in this age bracket, such as rhabdomyosarcoma, on the basis of imaging. The diagnosis is made on the basis of histopathological characteristics and is confirmed by immunohistochemical (IHC) analysis. Herein, we report a case of a six-year-old male child who presented with lower urinary tract symptoms and abdominal pain for a duration of two months. He was further evaluated using cross-sectional imaging, and histopathological examination with immunohistochemistry confirmed the diagnosis of NHL (Burkitt lymphoma). He was treated with one cycle of COP (cyclophosphamide, oncovin and prednisone), followed by one cycle of COPDAM (cyclophosphamide, oncovin, prednisone, doxorubicin (Adriamycin) and methotrexate). Follow-up contrast-enhanced computed tomography (CECT) revealed a 60% reduction in tumour size. This case highlights the importance of early diagnosis based on histopathology and IHC, and demonstrates that timely initiation of appropriate chemotherapy can lead to favourable outcomes in NHL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.